This study aimed to characterize adverse drug reactions (ADRs) to hydroxychloroquine in the setting of COVID-19, occurring in Italy in the period March to May 2020. The analysis of the combination therapy with azithromycin or/and lopinavir/ritonavir as well as a comparison with ADRs reported throughout 2019 was performed. ADRs collected by the Italian National Network of Pharmacovigilance were analyzed for their incidence, seriousness, outcome, coadministered drugs, and Medical Dictionary for Regulatory Activities classification. A total of 306 reports were gathered for the quarter of 2020: 54% nonserious and 46% serious, and half of the latter required either the hospitalization or its prolongation. However, most of them were either completely recovered (26%) or in the process of recovery (45%), except for 9 fatal cases. Throughout 2019, 38 reports were collected, 53% nonserious and 47% serious, but no deaths had been reported. Diarrhea, prolonged QT interval, and hypertransaminasemia were the most frequently ADRs reported in 2020, significantly higher than 2019 and specific for COVID-19 subjects treated with hydroxychloroquine. The logistic regression analyses demonstrated that the likelihood of serious ADRs, QT prolongation, and diarrhea significantly increased with hydroxychloroquine dosage. Coadministration of lopinavir/ritonavir and hydroxychloroquine showed a positive correlation with diarrhea and hypertransaminasemia and a negative relationship with the ADR seriousness. The combination therapy with azithromycin was another independent predictor of a serious ADR. Off-label use of hydroxychloroquine for COVID-19, alone or in combination regimens, was associated with increased incidence and/or seriousness of specific ADRs in patients with additional risk factors caused by the infection.
Marine Recreational Fishing (MRF) is a highly attended complex activity, extremely evident along the coastlines, and mainly practiced among riparian communities. For that reason, this activity plays an important role to effectively contribute to the collective well-being, both from the social and economic points of view. However, it may negatively affect the fish stocks and the marine environment in general, mainly due to the removal of biological resources. The growing need to evaluate the magnitude of marine recreational fishing is recognized worldwide, especially in the last decade, when inclusive fishing programs began to focus their attention on this fishing activity. Based on its unexpected evidence and its wider repercussion on social behavior, the COVID-19 pandemic is considered by the scientific community as one of the most unique opportunities to better understand the social phenomenon and their repercussion on the environment. In this work will be reported very preliminary results on the consistency of marine recreational fishing in the case study of the Marche region (Italy). Number of recreational fishers and fishing effort were estimated through a telephone survey conducted in the Italian side of the Northern Adriatic Sea (FAO GFCM Geographical Sub Area 17) by interviewing 580 households. The sampling strategy also included a recall survey, which was carried out every month on a list of recruited fishers. In this manner, additional information was collected, such as detailed fishing effort, catches, and expenditures. In addition, biological data of catches were estimated through several on-site surveys. The information collected from January and December 2020 was affected by the COVID-19 pandemic in terms of social restrictions and access to marine places, inevitably impacting on marine recreational fishing features, including the biological resources and the related economic aspects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.